Evidence mapPaperPMID 39245674Full record

ArticleAmerican journal of epidemiology2024

High-dimensional Iterative Causal Forest (hdiCF) for Subgroup Identification Using Health Care Claims Data.

Tiansheng Wang, Virginia Pate, Richard Wyss, John B Buse, Michael R Kosorok, Til Stürmer

Abstract read
In one paragraph

Article in American journal of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tiansheng WangDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Virginia PateDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Richard WyssDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
John B BuseDepartment of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Michael R KosorokDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Til StürmerDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Funding

Propensity scores and preventive drug use in the elderlyR01AG056479 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2025 to 2025
$558k
NIA NIH HHS R01 AG056479
6 · The paper itself

Abstract

We recently developed a machine-learning subgrouping algorithm, iterative causal forest (iCF), to identify subgroups with heterogeneous treatment effects (HTEs) using predefined covariates. However, such predefined covariates may miss or poorly define important features leading to inaccurate subgrouping. To address such limitations, we developed a new semi-automatic subgrouping algorithm, hdiCF, which adapts methodology from high-dimensional propensity score for feature recognition in claims data. The hdiCF algorithm has 3 steps: 1) high-dimensional feature identification by International Classification of Diseases, Current Procedural Terminology, and Anatomical Therapeutic Chemical codes (in/outpatient diagnoses, procedures, prescriptions) and creation of ordinal variables by frequency of occurrence; 2) propensity score trimming and high-dimensional feature preparation; 3) iCF implementation to identify subgroups. We applied hdiCF in a 20% random sample of fee-for-service Medicare beneficiaries who initiated sodium-glucose cotransporter-2 inhibitors (SGLT2i) or glucagon-like peptide-1 receptor agonists to identify subgroups with HTEs for incidence of hospitalized heart failure. HdiCF findings were consistent with studies suggesting SGLT2i to be more beneficial for patients with pre-existing heart failure or chronic kidney disease. HdiCF is not dependent on prior hypotheses about HTEs and identifies subgroups with markers for potential HTEs in real-world evidence studies where active-comparator, new-user study designs limit the potential for unmeasured confounding.

Indexed as

causal machine learningclaims dataheterogeneous treatment effecthigh-dimensionalIterative causal forestpharmacoepidemiologyprecision medicinesubgroup identification

Identifiers

PMID39245674
PMCPMC12234226

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.